Skip to content



From Code to Cure - using a predictive computational platform to discover untapped drug targets and extend the reach of cancer immunotherapies to new patient populations Pipeline. We are advancing new therapeutics and optimizing their combination to expand immuno-oncology treatment options to cancer patients who are refractory or unresponsive to currently available drugs.

Partner Type